ArticleEJIFCC2026
Unexplained Hypercobalaminemia: A Rare Diagnostic Pitfall.
Article in EJIFCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Persistently elevated serum vitamin B12 may suggest underlying pathology once analytical interferences are excluded. Here, we report a case of 56-year-old female with high vitamin B12 levels incidentally noted by primary care provider. Repeat testing with different assay method over time demonstrated consistently high values, prompting further evaluation. Hematology-oncology provider initiates malignancy workup due to well-documented association between neoplastic process and elevated vitamin B12 levels. Concurrently, clinical laboratory was contacted to rule out potential assay interference related to macro-vitamin B12 complexes. A polyethylene glycol precipitation study demonstrated markedly low vitamin B12 recovery, supporting the presence of a macro-vitamin B12 complex as the cause of spurious elevation. This case report highlights the importance of excluding macro-vitamin B12 interference prior to initiating extensive malignancy workup and the lack of evidence-based guidelines for the laboratory assessment of macro-complexes.
Indexed as
Identifiers
42729660PMC13563517What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.